Signalling to contractile proteins by muscarinic and purinergic pathways in neurally stimulated bladder smooth muscle

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Urinary bladder smooth muscle contraction is triggered by parasympathetic nerves, which release ATP and acetylcholine (ACh) that bind to purinergic and muscarinic receptors, respectively. Neuronal signalling may thus elicit myosin regulatory light chain (RLC) phosphorylation and contraction through the combined, but distinct contributions of these receptors. Both receptors mediate Ca 2+ influx whereas muscarinic receptors may also recruit Ca 2+-sensitization mechanisms. Using transgenic mice expressing calmodulin sensor myosin light chain kinase (MLCK) in smooth muscles, the effects of suramin/α,β-methyleneATP (α,β-meATP) (purinergic inhibition) or atropine (muscarinic inhibition) on neurally stimulated elevation of [Ca 2+] i, MLCK activation, force and phosphorylation of RLC, myosin light chain phosphatase (MLCP) targeting subunit MYPT1 and MLCP inhibitor protein CPI-17 were examined. Electric field stimulation (EFS) increased [Ca 2+] i, MLCK activation and concomitant force in a frequency-dependent manner. The dependence of force on [Ca 2+] i and MLCK activation decreased with time suggesting increased Ca 2+ sensitization in the late contractile phase. RLC and CPI-17 phosphorylation increased upon stimulation with maximal responses at 20 Hz; both responses were attenuated by atropine, but only RLC phosphorylation was inhibited by suramin/α,β-meATP. Antagonism of purinergic receptors suppressed maximal MLCK activation to a greater extent in the early contractile phase than in the late contractile phase; atropine had the opposite effect. A frequency- and time-dependent increase in MLCK phosphorylation explained the desensitization of MLCK to Ca 2+, since MLCK activation declined more rapidly than [Ca 2+] i. EFS elicited little or no effect on MYPT1 Thr696 or 850 phosphorylation. Thus, purinergic Ca 2+ signals provide the initial activation of MLCK with muscarinic receptors supporting sustained responses. Activation of muscarinic receptors recruits CPI-17, but not MYPT1-mediated Ca 2+ sensitization. Furthermore, nerve-released ACh also initiates signalling cascades leading to phosphorylation-dependent desensitization of MLCK.

Original languageEnglish (US)
Pages (from-to)5107-5121
Number of pages15
JournalJournal of Physiology
Volume590
Issue number20
DOIs
StatePublished - Oct 2012

Fingerprint

Myosin-Light-Chain Kinase
Contractile Proteins
Cholinergic Agents
Smooth Muscle
Urinary Bladder
Phosphorylation
Muscarinic Receptors
Atropine
Myosin-Light-Chain Phosphatase
Purinergic Receptors
Suramin
Light
Electric Stimulation
Acetylcholine
Myosin Light Chains
Calmodulin
Muscle Contraction
Transgenic Mice
Adenosine Triphosphate

ASJC Scopus subject areas

  • Physiology

Cite this

@article{26761d4f9e784af9bec8adbfee426238,
title = "Signalling to contractile proteins by muscarinic and purinergic pathways in neurally stimulated bladder smooth muscle",
abstract = "Urinary bladder smooth muscle contraction is triggered by parasympathetic nerves, which release ATP and acetylcholine (ACh) that bind to purinergic and muscarinic receptors, respectively. Neuronal signalling may thus elicit myosin regulatory light chain (RLC) phosphorylation and contraction through the combined, but distinct contributions of these receptors. Both receptors mediate Ca 2+ influx whereas muscarinic receptors may also recruit Ca 2+-sensitization mechanisms. Using transgenic mice expressing calmodulin sensor myosin light chain kinase (MLCK) in smooth muscles, the effects of suramin/α,β-methyleneATP (α,β-meATP) (purinergic inhibition) or atropine (muscarinic inhibition) on neurally stimulated elevation of [Ca 2+] i, MLCK activation, force and phosphorylation of RLC, myosin light chain phosphatase (MLCP) targeting subunit MYPT1 and MLCP inhibitor protein CPI-17 were examined. Electric field stimulation (EFS) increased [Ca 2+] i, MLCK activation and concomitant force in a frequency-dependent manner. The dependence of force on [Ca 2+] i and MLCK activation decreased with time suggesting increased Ca 2+ sensitization in the late contractile phase. RLC and CPI-17 phosphorylation increased upon stimulation with maximal responses at 20 Hz; both responses were attenuated by atropine, but only RLC phosphorylation was inhibited by suramin/α,β-meATP. Antagonism of purinergic receptors suppressed maximal MLCK activation to a greater extent in the early contractile phase than in the late contractile phase; atropine had the opposite effect. A frequency- and time-dependent increase in MLCK phosphorylation explained the desensitization of MLCK to Ca 2+, since MLCK activation declined more rapidly than [Ca 2+] i. EFS elicited little or no effect on MYPT1 Thr696 or 850 phosphorylation. Thus, purinergic Ca 2+ signals provide the initial activation of MLCK with muscarinic receptors supporting sustained responses. Activation of muscarinic receptors recruits CPI-17, but not MYPT1-mediated Ca 2+ sensitization. Furthermore, nerve-released ACh also initiates signalling cascades leading to phosphorylation-dependent desensitization of MLCK.",
author = "Tsai, {Ming Ho} and Kamm, {Kristine E.} and Stull, {James T.}",
year = "2012",
month = "10",
doi = "10.1113/jphysiol.2012.235424",
language = "English (US)",
volume = "590",
pages = "5107--5121",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "20",

}

TY - JOUR

T1 - Signalling to contractile proteins by muscarinic and purinergic pathways in neurally stimulated bladder smooth muscle

AU - Tsai, Ming Ho

AU - Kamm, Kristine E.

AU - Stull, James T.

PY - 2012/10

Y1 - 2012/10

N2 - Urinary bladder smooth muscle contraction is triggered by parasympathetic nerves, which release ATP and acetylcholine (ACh) that bind to purinergic and muscarinic receptors, respectively. Neuronal signalling may thus elicit myosin regulatory light chain (RLC) phosphorylation and contraction through the combined, but distinct contributions of these receptors. Both receptors mediate Ca 2+ influx whereas muscarinic receptors may also recruit Ca 2+-sensitization mechanisms. Using transgenic mice expressing calmodulin sensor myosin light chain kinase (MLCK) in smooth muscles, the effects of suramin/α,β-methyleneATP (α,β-meATP) (purinergic inhibition) or atropine (muscarinic inhibition) on neurally stimulated elevation of [Ca 2+] i, MLCK activation, force and phosphorylation of RLC, myosin light chain phosphatase (MLCP) targeting subunit MYPT1 and MLCP inhibitor protein CPI-17 were examined. Electric field stimulation (EFS) increased [Ca 2+] i, MLCK activation and concomitant force in a frequency-dependent manner. The dependence of force on [Ca 2+] i and MLCK activation decreased with time suggesting increased Ca 2+ sensitization in the late contractile phase. RLC and CPI-17 phosphorylation increased upon stimulation with maximal responses at 20 Hz; both responses were attenuated by atropine, but only RLC phosphorylation was inhibited by suramin/α,β-meATP. Antagonism of purinergic receptors suppressed maximal MLCK activation to a greater extent in the early contractile phase than in the late contractile phase; atropine had the opposite effect. A frequency- and time-dependent increase in MLCK phosphorylation explained the desensitization of MLCK to Ca 2+, since MLCK activation declined more rapidly than [Ca 2+] i. EFS elicited little or no effect on MYPT1 Thr696 or 850 phosphorylation. Thus, purinergic Ca 2+ signals provide the initial activation of MLCK with muscarinic receptors supporting sustained responses. Activation of muscarinic receptors recruits CPI-17, but not MYPT1-mediated Ca 2+ sensitization. Furthermore, nerve-released ACh also initiates signalling cascades leading to phosphorylation-dependent desensitization of MLCK.

AB - Urinary bladder smooth muscle contraction is triggered by parasympathetic nerves, which release ATP and acetylcholine (ACh) that bind to purinergic and muscarinic receptors, respectively. Neuronal signalling may thus elicit myosin regulatory light chain (RLC) phosphorylation and contraction through the combined, but distinct contributions of these receptors. Both receptors mediate Ca 2+ influx whereas muscarinic receptors may also recruit Ca 2+-sensitization mechanisms. Using transgenic mice expressing calmodulin sensor myosin light chain kinase (MLCK) in smooth muscles, the effects of suramin/α,β-methyleneATP (α,β-meATP) (purinergic inhibition) or atropine (muscarinic inhibition) on neurally stimulated elevation of [Ca 2+] i, MLCK activation, force and phosphorylation of RLC, myosin light chain phosphatase (MLCP) targeting subunit MYPT1 and MLCP inhibitor protein CPI-17 were examined. Electric field stimulation (EFS) increased [Ca 2+] i, MLCK activation and concomitant force in a frequency-dependent manner. The dependence of force on [Ca 2+] i and MLCK activation decreased with time suggesting increased Ca 2+ sensitization in the late contractile phase. RLC and CPI-17 phosphorylation increased upon stimulation with maximal responses at 20 Hz; both responses were attenuated by atropine, but only RLC phosphorylation was inhibited by suramin/α,β-meATP. Antagonism of purinergic receptors suppressed maximal MLCK activation to a greater extent in the early contractile phase than in the late contractile phase; atropine had the opposite effect. A frequency- and time-dependent increase in MLCK phosphorylation explained the desensitization of MLCK to Ca 2+, since MLCK activation declined more rapidly than [Ca 2+] i. EFS elicited little or no effect on MYPT1 Thr696 or 850 phosphorylation. Thus, purinergic Ca 2+ signals provide the initial activation of MLCK with muscarinic receptors supporting sustained responses. Activation of muscarinic receptors recruits CPI-17, but not MYPT1-mediated Ca 2+ sensitization. Furthermore, nerve-released ACh also initiates signalling cascades leading to phosphorylation-dependent desensitization of MLCK.

UR - http://www.scopus.com/inward/record.url?scp=84867479200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867479200&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2012.235424

DO - 10.1113/jphysiol.2012.235424

M3 - Article

VL - 590

SP - 5107

EP - 5121

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 20

ER -